Global Osteoarthritis Pain Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of Osteoarthritis Pain Drugs will have significant change from previous year. According to our latest study, the global Osteoarthritis Pain Drugs market size is USD million in 2022 from USD 9601.5 million in 2021, with a change of % between 2021 and 2022. The global Osteoarthritis Pain Drugs market size will reach USD 14350 million in 2028, growing at a CAGR of 5.9% over the analysis period.
The United States Osteoarthritis Pain Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Osteoarthritis Pain Drugs market, reaching US$ million by the year 2028. As for the Europe Osteoarthritis Pain Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Osteoarthritis Pain Drugs players cover Pfizer, Bayer, SK Chemicals, and GSK, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Pain Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injection
External
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medical Care
Personal Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson & Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Pain Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Osteoarthritis Pain Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Osteoarthritis Pain Drugs by Country/Region, 2017, 2022 & 2028
2.2 Osteoarthritis Pain Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Pain Drugs Sales by Type
2.3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2017-2022)
2.4 Osteoarthritis Pain Drugs Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Pain Drugs Sales by Application
2.5.1 Global Osteoarthritis Pain Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Osteoarthritis Pain Drugs Sale Price by Application (2017-2022)
3 Global Osteoarthritis Pain Drugs by Company
3.1 Global Osteoarthritis Pain Drugs Breakdown Data by Company
3.1.1 Global Osteoarthritis Pain Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Company (2020-2022)
3.2 Global Osteoarthritis Pain Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Company (2020-2022)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Osteoarthritis Pain Drugs Sale Price by Company
3.4 Key Manufacturers Osteoarthritis Pain Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osteoarthritis Pain Drugs Product Location Distribution
3.4.2 Players Osteoarthritis Pain Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Osteoarthritis Pain Drugs by Geographic Region
4.1 World Historic Osteoarthritis Pain Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Osteoarthritis Pain Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Osteoarthritis Pain Drugs Annual Revenue by Geographic Region
4.2 World Historic Osteoarthritis Pain Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Osteoarthritis Pain Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Osteoarthritis Pain Drugs Annual Revenue by Country/Region
4.3 Americas Osteoarthritis Pain Drugs Sales Growth
4.4 APAC Osteoarthritis Pain Drugs Sales Growth
4.5 Europe Osteoarthritis Pain Drugs Sales Growth
4.6 Middle East & Africa Osteoarthritis Pain Drugs Sales Growth
5 Americas
5.1 Americas Osteoarthritis Pain Drugs Sales by Country
5.1.1 Americas Osteoarthritis Pain Drugs Sales by Country (2017-2022)
5.1.2 Americas Osteoarthritis Pain Drugs Revenue by Country (2017-2022)
5.2 Americas Osteoarthritis Pain Drugs Sales by Type
5.3 Americas Osteoarthritis Pain Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osteoarthritis Pain Drugs Sales by Region
6.1.1 APAC Osteoarthritis Pain Drugs Sales by Region (2017-2022)
6.1.2 APAC Osteoarthritis Pain Drugs Revenue by Region (2017-2022)
6.2 APAC Osteoarthritis Pain Drugs Sales by Type
6.3 APAC Osteoarthritis Pain Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Osteoarthritis Pain Drugs by Country
7.1.1 Europe Osteoarthritis Pain Drugs Sales by Country (2017-2022)
7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2022)
7.2 Europe Osteoarthritis Pain Drugs Sales by Type
7.3 Europe Osteoarthritis Pain Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Pain Drugs by Country
8.1.1 Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Osteoarthritis Pain Drugs Sales by Type
8.3 Middle East & Africa Osteoarthritis Pain Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osteoarthritis Pain Drugs
10.3 Manufacturing Process Analysis of Osteoarthritis Pain Drugs
10.4 Industry Chain Structure of Osteoarthritis Pain Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Osteoarthritis Pain Drugs Distributors
11.3 Osteoarthritis Pain Drugs Customer
12 World Forecast Review for Osteoarthritis Pain Drugs by Geographic Region
12.1 Global Osteoarthritis Pain Drugs Market Size Forecast by Region
12.1.1 Global Osteoarthritis Pain Drugs Forecast by Region (2023-2028)
12.1.2 Global Osteoarthritis Pain Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Osteoarthritis Pain Drugs Forecast by Type
12.7 Global Osteoarthritis Pain Drugs Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Osteoarthritis Pain Drugs Product Offered
13.1.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Osteoarthritis Pain Drugs Product Offered
13.2.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 SK Chemicals
13.3.1 SK Chemicals Company Information
13.3.2 SK Chemicals Osteoarthritis Pain Drugs Product Offered
13.3.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 SK Chemicals Main Business Overview
13.3.5 SK Chemicals Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Osteoarthritis Pain Drugs Product Offered
13.4.3 GSK Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Osteoarthritis Pain Drugs Product Offered
13.5.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Crystal Genomics
13.6.1 Crystal Genomics Company Information
13.6.2 Crystal Genomics Osteoarthritis Pain Drugs Product Offered
13.6.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Crystal Genomics Main Business Overview
13.6.5 Crystal Genomics Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Osteoarthritis Pain Drugs Product Offered
13.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Sino Biopharmaceutical
13.8.1 Sino Biopharmaceutical Company Information
13.8.2 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offered
13.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sino Biopharmaceutical Main Business Overview
13.8.5 Sino Biopharmaceutical Latest Developments
13.9 Haohai Biological
13.9.1 Haohai Biological Company Information
13.9.2 Haohai Biological Osteoarthritis Pain Drugs Product Offered
13.9.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Haohai Biological Main Business Overview
13.9.5 Haohai Biological Latest Developments
13.10 Zhejiang Chengyi Pharmaceutical
13.10.1 Zhejiang Chengyi Pharmaceutical Company Information
13.10.2 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offered
13.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zhejiang Chengyi Pharmaceutical Main Business Overview
13.10.5 Zhejiang Chengyi Pharmaceutical Latest Developments
13.11 Freda
13.11.1 Freda Company Information
13.11.2 Freda Osteoarthritis Pain Drugs Product Offered
13.11.3 Freda Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Freda Main Business Overview
13.11.5 Freda Latest Developments
13.12 Bright Future
13.12.1 Bright Future Company Information
13.12.2 Bright Future Osteoarthritis Pain Drugs Product Offered
13.12.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bright Future Main Business Overview
13.12.5 Bright Future Latest Developments
13.13 Jingfeng Pharmaceutical
13.13.1 Jingfeng Pharmaceutical Company Information
13.13.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offered
13.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jingfeng Pharmaceutical Main Business Overview
13.13.5 Jingfeng Pharmaceutical Latest Developments
13.14 Chugai Pharmaceutical
13.14.1 Chugai Pharmaceutical Company Information
13.14.2 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offered
13.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Chugai Pharmaceutical Main Business Overview
13.14.5 Chugai Pharmaceutical Latest Developments
13.15 Mikasa Seiyaku
13.15.1 Mikasa Seiyaku Company Information
13.15.2 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offered
13.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Mikasa Seiyaku Main Business Overview
13.15.5 Mikasa Seiyaku Latest Developments
13.16 Taisho Pharmaceutical
13.16.1 Taisho Pharmaceutical Company Information
13.16.2 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offered
13.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Taisho Pharmaceutical Main Business Overview
13.16.5 Taisho Pharmaceutical Latest Developments
13.17 Seikagaku Corporation
13.17.1 Seikagaku Corporation Company Information
13.17.2 Seikagaku Corporation Osteoarthritis Pain Drugs Product Offered
13.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Seikagaku Corporation Main Business Overview
13.17.5 Seikagaku Corporation Latest Developments
13.18 GlaxoSmithKline
13.18.1 GlaxoSmithKline Company Information
13.18.2 GlaxoSmithKline Osteoarthritis Pain Drugs Product Offered
13.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 GlaxoSmithKline Main Business Overview
13.18.5 GlaxoSmithKline Latest Developments
13.19 Eli Lilly
13.19.1 Eli Lilly Company Information
13.19.2 Eli Lilly Osteoarthritis Pain Drugs Product Offered
13.19.3 Eli Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Eli Lilly Main Business Overview
13.19.5 Eli Lilly Latest Developments
13.20 Novartis
13.20.1 Novartis Company Information
13.20.2 Novartis Osteoarthritis Pain Drugs Product Offered
13.20.3 Novartis Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Novartis Main Business Overview
13.20.5 Novartis Latest Developments
13.21 Horizon Pharma
13.21.1 Horizon Pharma Company Information
13.21.2 Horizon Pharma Osteoarthritis Pain Drugs Product Offered
13.21.3 Horizon Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Horizon Pharma Main Business Overview
13.21.5 Horizon Pharma Latest Developments
13.22 Abbott
13.22.1 Abbott Company Information
13.22.2 Abbott Osteoarthritis Pain Drugs Product Offered
13.22.3 Abbott Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Abbott Main Business Overview
13.22.5 Abbott Latest Developments
13.23 Mylan
13.23.1 Mylan Company Information
13.23.2 Mylan Osteoarthritis Pain Drugs Product Offered
13.23.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Mylan Main Business Overview
13.23.5 Mylan Latest Developments
13.24 Daiichi Sankyo
13.24.1 Daiichi Sankyo Company Information
13.24.2 Daiichi Sankyo Osteoarthritis Pain Drugs Product Offered
13.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Daiichi Sankyo Main Business Overview
13.24.5 Daiichi Sankyo Latest Developments
13.25 TEVA
13.25.1 TEVA Company Information
13.25.2 TEVA Osteoarthritis Pain Drugs Product Offered
13.25.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 TEVA Main Business Overview
13.25.5 TEVA Latest Developments
13.26 Almatica Pharma
13.26.1 Almatica Pharma Company Information
13.26.2 Almatica Pharma Osteoarthritis Pain Drugs Product Offered
13.26.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Almatica Pharma Main Business Overview
13.26.5 Almatica Pharma Latest Developments
13.27 Astellas Pharma
13.27.1 Astellas Pharma Company Information
13.27.2 Astellas Pharma Osteoarthritis Pain Drugs Product Offered
13.27.3 Astellas Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Astellas Pharma Main Business Overview
13.27.5 Astellas Pharma Latest Developments
13.28 Tide Pharmaceutical
13.28.1 Tide Pharmaceutical Company Information
13.28.2 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Offered
13.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Tide Pharmaceutical Main Business Overview
13.28.5 Tide Pharmaceutical Latest Developments
13.29 Iroko Pharmaceuticals
13.29.1 Iroko Pharmaceuticals Company Information
13.29.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offered
13.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 Iroko Pharmaceuticals Main Business Overview
13.29.5 Iroko Pharmaceuticals Latest Developments
13.30 Hengrui Pharmaceutical
13.30.1 Hengrui Pharmaceutical Company Information
13.30.2 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Offered
13.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.30.4 Hengrui Pharmaceutical Main Business Overview
13.30.5 Hengrui Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Osteoarthritis Pain Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Osteoarthritis Pain Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of External
Table 6. Global Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
Table 7. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Osteoarthritis Pain Drugs Sale Price by Type (2017-2022) & (US$/Dose)
Table 11. Global Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
Table 12. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Osteoarthritis Pain Drugs Revenue by Application (2017-2022)
Table 14. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Osteoarthritis Pain Drugs Sale Price by Application (2017-2022) & (US$/Dose)
Table 16. Global Osteoarthritis Pain Drugs Sales by Company (2020-2022) & (M Dose)
Table 17. Global Osteoarthritis Pain Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Osteoarthritis Pain Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Osteoarthritis Pain Drugs Sale Price by Company (2020-2022) & (US$/Dose)
Table 21. Key Manufacturers Osteoarthritis Pain Drugs Producing Area Distribution and Sales Area
Table 22. Players Osteoarthritis Pain Drugs Products Offered
Table 23. Osteoarthritis Pain Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Osteoarthritis Pain Drugs Sales by Geographic Region (2017-2022) & (M Dose)
Table 27. Global Osteoarthritis Pain Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Osteoarthritis Pain Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Osteoarthritis Pain Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Osteoarthritis Pain Drugs Sales by Country/Region (2017-2022) & (M Dose)
Table 31. Global Osteoarthritis Pain Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Osteoarthritis Pain Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Osteoarthritis Pain Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
Table 35. Americas Osteoarthritis Pain Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Osteoarthritis Pain Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
Table 39. Americas Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
Table 41. Americas Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Osteoarthritis Pain Drugs Sales by Region (2017-2022) & (M Dose)
Table 43. APAC Osteoarthritis Pain Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Osteoarthritis Pain Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Osteoarthritis Pain Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
Table 47. APAC Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
Table 49. APAC Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
Table 51. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
Table 55. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
Table 57. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
Table 59. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
Table 63. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
Table 65. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Osteoarthritis Pain Drugs
Table 67. Key Market Challenges & Risks of Osteoarthritis Pain Drugs
Table 68. Key Industry Trends of Osteoarthritis Pain Drugs
Table 69. Osteoarthritis Pain Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Osteoarthritis Pain Drugs Distributors List
Table 72. Osteoarthritis Pain Drugs Customer List
Table 73. Global Osteoarthritis Pain Drugs Sales Forecast by Region (2023-2028) & (M Dose)
Table 74. Global Osteoarthritis Pain Drugs Sales Market Forecast by Region
Table 75. Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Osteoarthritis Pain Drugs Sales Forecast by Country (2023-2028) & (M Dose)
Table 78. Americas Osteoarthritis Pain Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Osteoarthritis Pain Drugs Sales Forecast by Region (2023-2028) & (M Dose)
Table 80. APAC Osteoarthritis Pain Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Osteoarthritis Pain Drugs Sales Forecast by Country (2023-2028) & (M Dose)
Table 82. Europe Osteoarthritis Pain Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Osteoarthritis Pain Drugs Sales Forecast by Country (2023-2028) & (M Dose)
Table 84. Middle East & Africa Osteoarthritis Pain Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2023-2028) & (M Dose)
Table 86. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2023-2028) & (M Dose)
Table 90. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Osteoarthritis Pain Drugs Product Offered
Table 95. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Bayer Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer Osteoarthritis Pain Drugs Product Offered
Table 100. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 101. Bayer Main Business
Table 102. Bayer Latest Developments
Table 103. SK Chemicals Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. SK Chemicals Osteoarthritis Pain Drugs Product Offered
Table 105. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 106. SK Chemicals Main Business
Table 107. SK Chemicals Latest Developments
Table 108. GSK Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. GSK Osteoarthritis Pain Drugs Product Offered
Table 110. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 111. GSK Main Business
Table 112. GSK Latest Developments
Table 113. Sanofi Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sanofi Osteoarthritis Pain Drugs Product Offered
Table 115. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 116. Sanofi Main Business
Table 117. Sanofi Latest Developments
Table 118. Crystal Genomics Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Crystal Genomics Osteoarthritis Pain Drugs Product Offered
Table 120. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 121. Crystal Genomics Main Business
Table 122. Crystal Genomics Latest Developments
Table 123. Johnson & Johnson Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Johnson & Johnson Osteoarthritis Pain Drugs Product Offered
Table 125. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Latest Developments
Table 128. Sino Biopharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 130. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 131. Sino Biopharmaceutical Main Business
Table 132. Sino Biopharmaceutical Latest Developments
Table 133. Haohai Biological Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Haohai Biological Osteoarthritis Pain Drugs Product Offered
Table 135. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 136. Haohai Biological Main Business
Table 137. Haohai Biological Latest Developments
Table 138. Zhejiang Chengyi Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 140. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 141. Zhejiang Chengyi Pharmaceutical Main Business
Table 142. Zhejiang Chengyi Pharmaceutical Latest Developments
Table 143. Freda Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Freda Osteoarthritis Pain Drugs Product Offered
Table 145. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 146. Freda Main Business
Table 147. Freda Latest Developments
Table 148. Bright Future Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Bright Future Osteoarthritis Pain Drugs Product Offered
Table 150. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 151. Bright Future Main Business
Table 152. Bright Future Latest Developments
Table 153. Jingfeng Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 155. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 156. Jingfeng Pharmaceutical Main Business
Table 157. Jingfeng Pharmaceutical Latest Developments
Table 158. Chugai Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 160. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 161. Chugai Pharmaceutical Main Business
Table 162. Chugai Pharmaceutical Latest Developments
Table 163. Mikasa Seiyaku Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offered
Table 165. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 166. Mikasa Seiyaku Main Business
Table 167. Mikasa Seiyaku Latest Developments
Table 168. Taisho Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 170. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 171. Taisho Pharmaceutical Main Business
Table 172. Taisho Pharmaceutical Latest Developments
Table 173. Seikagaku Corporation Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 174. Seikagaku Corporation Osteoarthritis Pain Drugs Product Offered
Table 175. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 176. Seikagaku Corporation Main Business
Table 177. Seikagaku Corporation Latest Developments
Table 178. GlaxoSmithKline Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 179. GlaxoSmithKline Osteoarthritis Pain Drugs Product Offered
Table 180. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 181. GlaxoSmithKline Main Business
Table 182. GlaxoSmithKline Latest Developments
Table 183. Eli Lilly Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 184. Eli Lilly Osteoarthritis Pain Drugs Product Offered
Table 185. Eli Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 186. Eli Lilly Main Business
Table 187. Eli Lilly Latest Developments
Table 188. Novartis Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 189. Novartis Osteoarthritis Pain Drugs Product Offered
Table 190. Novartis Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 191. Novartis Main Business
Table 192. Novartis Latest Developments
Table 193. Horizon Pharma Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 194. Horizon Pharma Osteoarthritis Pain Drugs Product Offered
Table 195. Horizon Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 196. Horizon Pharma Main Business
Table 197. Horizon Pharma Latest Developments
Table 198. Abbott Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 199. Abbott Osteoarthritis Pain Drugs Product Offered
Table 200. Abbott Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 201. Abbott Main Business
Table 202. Abbott Latest Developments
Table 203. Mylan Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 204. Mylan Osteoarthritis Pain Drugs Product Offered
Table 205. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 206. Mylan Main Business
Table 207. Mylan Latest Developments
Table 208. Daiichi Sankyo Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 209. Daiichi Sankyo Osteoarthritis Pain Drugs Product Offered
Table 210. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 211. Daiichi Sankyo Main Business
Table 212. Daiichi Sankyo Latest Developments
Table 213. TEVA Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 214. TEVA Osteoarthritis Pain Drugs Product Offered
Table 215. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 216. TEVA Main Business
Table 217. TEVA Latest Developments
Table 218. Almatica Pharma Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 219. Almatica Pharma Osteoarthritis Pain Drugs Product Offered
Table 220. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 221. Almatica Pharma Main Business
Table 222. Almatica Pharma Latest Developments
Table 223. Astellas Pharma Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 224. Astellas Pharma Osteoarthritis Pain Drugs Product Offered
Table 225. Astellas Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 226. Astellas Pharma Main Business
Table 227. Astellas Pharma Latest Developments
Table 228. Tide Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 229. Tide Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 230. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 231. Tide Pharmaceutical Main Business
Table 232. Tide Pharmaceutical Latest Developments
Table 233. Iroko Pharmaceuticals Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 234. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offered
Table 235. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 236. Iroko Pharmaceuticals Main Business
Table 237. Iroko Pharmaceuticals Latest Developments
Table 238. Hengrui Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 239. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Offered
Table 240. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 241. Hengrui Pharmaceutical Main Business
Table 242. Hengrui Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Osteoarthritis Pain Drugs
Figure 2. Osteoarthritis Pain Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osteoarthritis Pain Drugs Sales Growth Rate 2017-2028 (M Dose)
Figure 7. Global Osteoarthritis Pain Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Osteoarthritis Pain Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of External
Figure 12. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2021
Figure 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Osteoarthritis Pain Drugs Consumed in Medical Care
Figure 15. Global Osteoarthritis Pain Drugs Market: Medical Care (2017-2022) & (M Dose)
Figure 16. Osteoarthritis Pain Drugs Consumed in Personal Care
Figure 17. Global Osteoarthritis Pain Drugs Market: Personal Care (2017-2022) & (M Dose)
Figure 18. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2022)
Figure 19. Global Osteoarthritis Pain Drugs Revenue Market Share by Application in 2021
Figure 20. Osteoarthritis Pain Drugs Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2021
Figure 22. Global Osteoarthritis Pain Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Osteoarthritis Pain Drugs Revenue Market Share by Geographic Region in 2021
Figure 24. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2017-2022)
Figure 25. Global Osteoarthritis Pain Drugs Revenue Market Share by Country/Region in 2021
Figure 26. Americas Osteoarthritis Pain Drugs Sales 2017-2022 (M Dose)
Figure 27. Americas Osteoarthritis Pain Drugs Revenue 2017-2022 ($ Millions)
Figure 28. APAC Osteoarthritis Pain Drugs Sales 2017-2022 (M Dose)
Figure 29. APAC Osteoarthritis Pain Drugs Revenue 2017-2022 ($ Millions)
Figure 30. Europe Osteoarthritis Pain Drugs Sales 2017-2022 (M Dose)
Figure 31. Europe Osteoarthritis Pain Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Osteoarthritis Pain Drugs Sales 2017-2022 (M Dose)
Figure 33. Middle East & Africa Osteoarthritis Pain Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Americas Osteoarthritis Pain Drugs Sales Market Share by Country in 2021
Figure 35. Americas Osteoarthritis Pain Drugs Revenue Market Share by Country in 2021
Figure 36. United States Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Osteoarthritis Pain Drugs Sales Market Share by Region in 2021
Figure 41. APAC Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2021
Figure 42. China Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Osteoarthritis Pain Drugs Sales Market Share by Country in 2021
Figure 49. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country in 2021
Figure 50. Germany Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country in 2021
Figure 57. Egypt Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Osteoarthritis Pain Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Osteoarthritis Pain Drugs in 2021
Figure 63. Manufacturing Process Analysis of Osteoarthritis Pain Drugs
Figure 64. Industry Chain Structure of Osteoarthritis Pain Drugs
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
